Nuveen LLC purchased a new stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 5,240,628 shares of the enterprise software provider's stock, valued at approximately $732,692,000. Nuveen LLC owned about 0.19% of Oracle at the end of the most recent quarter.
A number of other institutional investors have also bought and sold shares of ORCL. Aveo Capital Partners LLC raised its holdings in shares of Oracle by 47.0% during the first quarter. Aveo Capital Partners LLC now owns 3,318 shares of the enterprise software provider's stock valued at $496,000 after purchasing an additional 1,061 shares during the period. Virtu Financial LLC raised its holdings in shares of Oracle by 1,277.3% during the first quarter. Virtu Financial LLC now owns 25,535 shares of the enterprise software provider's stock valued at $3,570,000 after purchasing an additional 23,681 shares during the period. Polen Capital Management LLC raised its holdings in shares of Oracle by 17.6% during the first quarter. Polen Capital Management LLC now owns 12,609,101 shares of the enterprise software provider's stock valued at $1,762,878,000 after purchasing an additional 1,885,370 shares during the period. AFT Forsyth & Company Inc. raised its holdings in shares of Oracle by 4.2% during the first quarter. AFT Forsyth & Company Inc. now owns 7,024 shares of the enterprise software provider's stock valued at $982,000 after purchasing an additional 285 shares during the period. Finally, Pandora Wealth Inc. acquired a new stake in shares of Oracle in the 1st quarter worth about $297,000. Institutional investors own 42.44% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on the stock. Citigroup upgraded shares of Oracle from a "hold" rating to a "strong-buy" rating in a report on Friday, July 18th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a $240.00 target price (up previously from $200.00) on shares of Oracle in a report on Thursday, June 12th. Guggenheim upped their target price on shares of Oracle from $220.00 to $250.00 and gave the stock a "buy" rating in a report on Wednesday, June 18th. Scotiabank began coverage on shares of Oracle in a research report on Thursday, July 17th. They issued a "sector outperform" rating and a $300.00 price objective for the company. Finally, JPMorgan Chase & Co. upped their price objective on shares of Oracle from $135.00 to $185.00 and gave the stock a "neutral" rating in a research report on Thursday, June 12th. Nine investment analysts have rated the stock with a hold rating, twenty-three have assigned a buy rating and three have assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $222.75.
Get Our Latest Analysis on Oracle
Insider Activity
In related news, insider Clayton M. Magouyrk sold 15,000 shares of Oracle stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $214.10, for a total value of $3,211,500.00. Following the transaction, the insider owned 60,722 shares in the company, valued at $13,000,580.20. This trade represents a 19.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Rona Alison Fairhead bought 480 shares of the firm's stock in a transaction that occurred on Monday, July 7th. The stock was acquired at an average price of $233.87 per share, for a total transaction of $112,257.60. Following the transaction, the director owned 22,110 shares in the company, valued at $5,170,865.70. This trade represents a 2.22% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have sold 444,183 shares of company stock worth $86,521,198. Corporate insiders own 42.20% of the company's stock.
Oracle Price Performance
NYSE:ORCL traded up $0.65 during trading hours on Friday, hitting $250.04. The stock had a trading volume of 8,301,832 shares, compared to its average volume of 10,261,765. The company has a 50 day simple moving average of $222.64 and a two-hundred day simple moving average of $177.75. The company has a debt-to-equity ratio of 4.07, a current ratio of 0.75 and a quick ratio of 0.75. Oracle Corporation has a one year low of $118.86 and a one year high of $260.87. The firm has a market capitalization of $702.32 billion, a price-to-earnings ratio of 57.61, a P/E/G ratio of 3.73 and a beta of 1.43.
Oracle (NYSE:ORCL - Get Free Report) last announced its quarterly earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, beating the consensus estimate of $1.64 by $0.06. Oracle had a net margin of 21.68% and a return on equity of 87.34%. The firm had revenue of $15.90 billion during the quarter, compared to the consensus estimate of $15.58 billion. During the same period last year, the firm earned $1.63 EPS. The business's quarterly revenue was up 11.3% compared to the same quarter last year. Research analysts forecast that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, July 24th. Stockholders of record on Thursday, July 10th were given a dividend of $0.50 per share. The ex-dividend date was Thursday, July 10th. This represents a $2.00 annualized dividend and a dividend yield of 0.8%. Oracle's dividend payout ratio (DPR) is 46.08%.
About Oracle
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report